Document is current

Any future updates will be listed below

IL28B genotype predicts response to chronic hepatitis C triple therapy with telaprevir or boceprevir in treatment naïve and treatment-experienced patients other than prior partial- and null-responders

Crossref DOI link: https://doi.org/10.1186/s40064-015-1137-x

Published Online: 2015-07-16

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark